Detalhe da pesquisa
1.
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Cell
; 176(3): 564-580.e19, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580964
2.
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
Nature
; 609(7926): 408-415, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831509
3.
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Cell
; 148(1-2): 244-58, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265415
4.
Noncoding RNAs: the missing "linc" in p53-mediated repression.
Cell
; 142(3): 358-60, 2010 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20691894
5.
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
Mol Cell
; 48(5): 799-810, 2012 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23102701
6.
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.
EMBO J
; 34(13): 1773-85, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25979827
7.
p53-Dependent induction of PVT1 and miR-1204.
J Biol Chem
; 287(4): 2509-19, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22110125
8.
Recruitment of FBXO22 for Targeted Degradation of NSD2.
bioRxiv
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961297
9.
Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors.
Cell Chem Biol
; 29(3): 423-435.e10, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34715056
10.
A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.
Proc Natl Acad Sci U S A
; 105(6): 1937-42, 2008 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18238895
11.
Discovery and Optimization of Glucose Uptake Inhibitors.
J Med Chem
; 63(10): 5201-5211, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282207
12.
Organizational injury rate underreporting: the moderating effect of organizational safety climate.
J Appl Psychol
; 93(5): 1147-54, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18808232
13.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget
; 6(5): 2928-38, 2015 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25671303
14.
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
Epigenomics
; 7(5): 687-90, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317265
15.
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner.
Cell Cycle
; 7(9): 1133-8, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18418048